Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 114.00
-2.40 (-2.06%)
Apr 24, 2025, 3:44 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 573.21 million as of April 24, 2025. Its market cap has increased by 78.88% in one year.
Market Cap
573.21M
Enterprise Value
535.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
114.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 573.21M, an increase of 398.28%. That is a compound annual growth rate of 59.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 573.21M | 32.88% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.07B |
| Synektik Spólka Akcyjna | 1.76B |
| Voxel | 1.45B |
| Celon Pharma | 1.36B |
| Ryvu Therapeutics | 725.97M |
| Centrum Medyczne ENEL-MED | 551.47M |
| Selvita | 550.66M |
| Scope Fluidics | 489.58M |